Valid to: 14/10/13. Superseded version number and date (if applicable): 1: 26 Nov 2009
|
|
- Benjamin Parsons
- 6 years ago
- Views:
Transcription
1 Document Number: SOP/23/V2 Title: Assessment of Atopic Dermatitis in children using SCORAD Author: Susan MacFarlane Version 2 Date created: 5 Jan 2010 Effective from: 14/10/10 Superseded version number and date (if applicable): 1: 26 Nov Purpose 1.1 This Standard Operating Procedure (SOP) describes the correct procedure for the assessment of Atopic Dermatitis (AD) in children and young people using the SCORAD scale. 1.2 SCORAD ("SCORing Atopic Dermatitis") is a clinical tool for assessing the severity (i.e. extent, intensity) of Atopic Dermatitis as objectively as possible (Appendix 1). 1.3 SCORAD is used in clinical trials to evaluate disease improvement during and after treatment. 1.4 The European Task Force on Atopic Dermatitis (ETFAD) developed SCORAD to create a consensus on assessment methods for AD, so that study results can be compared. 1.5 To measure the extent of AD, the Rule of Nines is applied on a front/back drawing of the child s inflammatory regions. The rule of nines is a method used when calculating body surface area, originally used for burns where values of 9 or 18% of surface area are assigned to specific regions (Appendix 2). This rule accounts for inequities in size, weight and shape to calculate a percentage of total body area. For partially affected areas the percentage is approximated. 1.6 The SCORAD identifies the intensity of six items: erythema, oedema/population, excoriations, lichenification, oozing/crusts and dryness. 1.7 The SCORAD identifies subjective items using visual analogue scales for daily pruritis and sleep disturbance. 2.0 Scope This SOP applies to the correct procedure to be followed by the Principal Investigator, medical staff and research staff when assessing a child or young person s skin for the severity and extent of Atopic Dermatitis as a component of a research study. Page 1 of 5
2 3.0 Responsibilities 3.1 Staff must ensure they have received the appropriate training on the SCORAD tool and be familiar with completion instructions and calculations. All items must be completed to ensure an accurate score. 3.2 SCORAD assessment will only be carried out to assess the skin of children with diagnosed Atopic Dermatitis. 3.3 Staff completing the SCORAD must have a basic knowledge of Atopic Dermatitis scope, severity, and treatment. 4.0 Procedures 4.1 Introduce self to parent and child 4.2 Ensure child and parent are in a quiet, private, warm area 4.3 Ensure consent from parent and assent from child remain valid. 4.4 Discuss with parent and child the process of using the SCORAD tool. 4.5 Ask parent to assist child to remove clothing (leaving only underwear) to allow close observation of all of the skin, including front and back aspects of body. 4.6 If the child is uncomfortable, expose only affected skin areas as tolerated. 4.7 Ensure research staff member is using an age appropriate SCORAD tool. 4.8 Wash hands prior to touching, with permission from the child and parent, the child s skin to assess dryness and lichenification. 4.9 Complete SCORAD tool using the Rule of Nines shading the affected areas on the SCORAD diagram to provide an interpretation of the percentage of affected area. If only partial area is affected, only partial score is recorded. For example, if the diagram shows optimum score for the frontal aspect of the whole leg is 9 and only the lower half of the child s leg is affected then the score would be interpreted as 4.5 (Appendix 1, section A) Record the severity of symptoms using the identified scales (Appendix 1, section B) Discuss with parent and child where appropriate sleep loss and presentation of itch using the analogue scales found on SCORAD tool section C (Appendix 1) Using the identified equation calculate the SCORAD score and record on tool in the appropriate section (Appendix 1). Page 2 of 5
3 Additionally record the SCORAD score in participant s medical notes and in Case Report Form. Recheck calculation to ensure accuracy (Appendix 1) If two professionals are using SCORAD tool, discuss the results and record in the appropriate documentation The professional completing the SCORAD tool must sign and date in the appropriate section for identification and accountability as good clinical practice (Appendix 1) Ask parent to replace child s clothing Inform parent and child of the result of the SCORAD assessment and discuss with them any improvement or deterioration in extent of Atopic Dermatitis If SCORAD assessment meets the study inclusion criteria and/or study visit criteria arrange future study visit within identified time frames If SCORAD assessment does not meet study inclusion criteria and/or study visit criteria and indicates withdrawal from the study discuss with parent and child procedure to be followed in accordance with study protocol. If SCORAD has been completed by one person only ask a suitably qualified colleague to complete an assessment for comparison. Inform Principal Investigator (PI) of SCORAD assessment and protocol requirements and where possible PI should attend to recheck assessment. If PI and study personnel determine SCORAD assessment does not meet the protocol criteria complete end of study visit/early termination visit as identified in protocol and ensure routine dermatological clinical care has been arranged. 5.0 Related Documents Rule of Nine (Appendix 1). SCORAD Tool (Appendix 2). Case Report Form Study Specific Training 6.0 References ICH/GCP Directive/guidelines EU Clinical Trials Directive ORANIE, A et al Practical Issues on interpretation of scoring Atopic Dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. British Journal of Dermatology. 157(4): Online SCORAD Training Page 3 of 5
4 Approval: Name: Prof Peter Helms Position: Network Director Signature: Date: 14/10/10 APPENDIX 1 SCORAD Tool Page 4 of 5
5 APPENDIX 2 Rule of Nine for Children <2 years of age. Rule of Nine for Older Children and Adults Images reproduced for reference from; Page 5 of 5
2.2 Blood sampling can be done for various tests depending on the clinical research study.
Document Number: SOP/07/V3 Title: Obtaining a Blood Sample (capillary) in children and young people Author: Liz Waxman Version 3 Effective Date: 16/5/2014 Periodic Review Date: 15/5/2017 Superseded version
More informationA practical guide to Assessment tools used in Atopic Eczema. Sheila Ryan, RANP Dermatology
A practical guide to Assessment tools used in Atopic Eczema Sheila Ryan, RANP Dermatology Learning Outcomes Understand assessment tools used in Atopic Eczema POEM, IGA, EASI, SCORAD Be able to identify
More informationSCORAD and PO-SCORAD
SCORAD and PO-SCORAD Tools for assessing atopic eczema MetteDeleuran Department of Dermatology Aarhus University Hospital, Denmark SCORAD and PO-SCORAD Tools for assessing atopic eczema SCORAD: The doctors
More informationStudy Protocol Exploring the optimum number of repeated measures of disease severity in eczema clinical trials. Draft 1.0 / Final Version 1.
Study Protocol Exploring the optimum number of repeated measures of disease severity in eczema clinical trials. Draft 1.0 / Final Version 1.0 Short title: Funding Source: 26th September 2018 Repeated Measures
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable(s):
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More information1. Erythema. 2. Edema/papulation. 3. Excoriation 4. Lichenification
How to Use EASI The EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected: 1. Select a body region Four body regions are considered separately:
More informationThe EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected:
How to Use EASI The EASI scoring system uses a defined process to grade the severity of the signs of eczema and the extent affected: 1. Select a body region Four body regions are considered separately:
More informationPOLICY. Institutional Research Projects/Data Requests #7220
POLICY 1. This policy is intended to ensure that data requests and research projects conducted by any college office, employee, student, or affiliate are sound and that they do not violate board policy,
More informationECZTRA 3. Efficacy Assessment & C-SSRS Manual
ECZTRA 3 Efficacy Assessment & C-SSRS Manual LP0162 1339 Efficacy Assement & C SSRS Manual, v 1.0, 25 Jan 2018 Efficacy Assessments General instruction Investigator assessments should be performed after
More informationAdverse Childhood Experiences International Questionnaire (ACE-IQ) Ethical Approval Form
Adverse Childhood Experiences International Questionnaire (ACE-IQ) Ethical Approval Form Part 1: General Information Introduction The ethical approval process for ACE-IQ depends upon the broader survey
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationClinical Study Report Synopsis
Clinical Study Report Synopsis An Explorative Clinical Trial to Evaluate an Intra Patient Comparison Design of Topical Agents in Adults with Mild to Moderate Atopic Dermatitis Design of trial: Single-centre,
More informationDivision of Research University Policy
Division of Research University Policy SUBJECT: Effective Date: Policy Number: SATELLITE ANIMAL HOUSING FACILITIES June 24, 2016 Supersedes: August 22, 2014 1 5 Responsible Authorities: Vice President,
More informationPNW EPC Drug Effectiveness Review Project Summary Report Atopic Dermatitis New Drug Evaluation: Dupilumab
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationNaphthalene in the Treatment of Patients with Atopic Dermatitis
2007;15(1):15-19 SHORT SCIENTIFIC COMMUNICATION Naphthalene in the Treatment of Patients with Atopic Dermatitis Ankica Smeh-Skrbin 1, Ivan Dobrić 2, Gordana Krnjević-Pezić 1, Pero Vržogić 1 1 Naftalan
More informationHSPC/IRB Description of Research Form (For research projects involving human participants)
HSPC/IRB Description of Research Form (For research projects involving human participants) This form is to be completed by the Principal Investigator (P.I.) of the research project being submitted to the
More informationGUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON THE CONDUCT OF GCP INSPECTIONS BY COMPETENT AUTHORITIES OF THE DIFFERENT MEMBER STATES
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 5 November 2008 ENTR/F/2/SF D(2008) 34957 GUIDANCE DOCUMENTS CONTAINING THE COMMON PROVISIONS ON
More informationPNW EPC Drug Effectiveness Review Project Summary Report Atopic Dermatitis New Drug Evaluation: Dupilumab
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationComparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis
Original Article Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Md Alauddin Khan *, Lubna Khondker **, Dilshad
More informationDAILY CARE FOR DRY, IRRITATED AND REACTIVE SKIN. Physiogel A.I. Help your patients restore skin balance and well-being
DAILY CARE FOR DRY, IRRITATED AND REACTIVE SKIN Help your patients restore skin balance and well-being Dry, irritated and reactive skin a question of balance Changes in the lipid barrier (1) Neurological
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationStandard Operating Procedure:
Standard Operating Procedure: Name of procedure: Taking Informed Consent SOP Number: SOP07/UoE/HTA (includes Adverse Events Reporting Form) Version Number & Date: V5 16/01/2017 Review Date: Annually Superseded
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Site Initiation SOP-RES-010 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Rachelle
More informationAdministrative Procedure
Durham Catholic District School Board The Board Title: Eyewash Stations and Safety Showers Procedure #: AP414-12 Administrative Area: Policy Reference: Human Resources and Administrative Services Emergency
More informationHOW TO DEAL WITH SLEEP PROBLEMS
The Handbook on Successful Ageing HOW TO DEAL WITH SLEEP PROBLEMS Up to 50% of the elderly complain of insomnia, but although such complaints are prevalent and are often accompanied by higher rates of
More informationTURFLOOP RESEARCH ETHICS COMMITTEE APPLICATION FOR RESEARCH ETHICS CLEARANCE FORM A PART I PROJECT TITLE:. PROJECT LEADER/SUPERVISOR:
APPLICATION FOR RESEARCH ETHICS CLEARANCE Type in the required information. Complete only form A Part I and Part II for experimental research. Complete only form B Part I and Part II for research using
More informationFollow this and additional works at: Part of the Medicine and Health Sciences Commons
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Does coconut oil aid in improving the
More informationUnit 204 Assist with the assembly of prescribed items
Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential
More informationCONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY
CONSENT FORM TO PARTICIPATE IN A RESEARCH STUDY INVESTIGATOR S NAME: PAMELA S. HINTON PH.D. PROJECT # 1095877 DATE OF PROJECT APPROVAL: SEPTEMBER 12, 2007 STUDY TITLE: EFFICACY OF PLYOMETRICS TO INCREASE
More informationTopical Doxepin Prior Authorization with Quantity Limit Program Summary
Topical Doxepin Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-3 Agent(s) Indication(s) Dosage & Administration Doxepin 5% cream Prudoxin (doxepin) cream 5% KS_PS_Topical_Doxepin_PAQL_ProgSum_AR1018
More informationSTANDARD OPERATING PROCEDURE (SOP) #102
STANDARD OPERATING PROCEDURE (SOP) #102 SOP #102 Title: Guidelines for BMS National Database Recruitment, Consenting, and Withdrawal of Participants Approved by: BMS Project Directors Effective Date: 4/14/2014
More informationIRB Approval From: 3/8/2010 To: 10/28/2010
UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 (Version 3.0, 16 FEB 2010) IRB Approval From:
More informationDate First Issued: Date of Last Review: Date of Next Review: Version Number: 1.0
Document Type: Policy Area: Document Title: Policy Educlear FIRST AID Date First Issued: 01.10.2016 Date of Last Review: 01.10.2016 Date of Next Review: 01.10.2017 (minimum policy review to be within 2
More informationCerumen Management. Hospital Outpatient Agency Private clinic School Other
ADVANCED CERTIFICATION APPLICATION AND PROGRAM OF STUDY Advanced Certificate C Cerumen Management Registrant/AC Applicant Information (Registration status: must be Active) Name: Registration #: Training/employment
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationPathogenesis and Management of Atopic Dermatitis
Pathogenesis and Management of Atopic Dermatitis Current Problems in Dermatology Vol. 41 Series Editors Peter Itin Basel Gregor Jemec Roskilde Pathogenesis and Management of Atopic Dermatitis Volume Editor
More informationATOPIC DERMATITIS IN CHILDREN. Simple choice questions
ATOPIC DERMATITIS IN CHILDREN Simple choice questions 1. Which is the principal cause of atopic dermatitisdevelopment in little age children? A. Psychoemotional factors. B. Habitual antigens. C. Food allergy.
More informationClinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013
1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT
More informationContents. 1) Purpose ) Policy ) Definitions ) Procedure a) Requirements b) Noise standard... 4
Contents 1) Purpose... 3 2) Policy... 3 3) Definitions... 3 4) Procedure... 4 a) Requirements... 4 b) Noise standard... 4 c) Responsibilites... 5 d) Exposure Monitoring and Assessments... 6 e) Employee
More informationLeuven Itch Scale 1.0. Manual
Leuven Itch Scale 1.0 Manual Version: February 2015 Contact information Philip Moons Center for Health Services and Nursing Research Katholieke Universiteit Leuven E-mail: Philip.Moons@med.kuleuven.be
More informationSTANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED. BY THE NNUH and UEA
STANDARD OPERATING PROCEDURE SOP 720 RISK ASSESSMENT OF TRIALS SPONSORED BY THE NNUH and UEA Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 11 pages Review date November
More informationStandard operating procedure
Standard operating procedure Title: Early Notification System: procedure for advanced notification of emerging safety issues to EU regulatory network and international partners Status: PUBLIC Document
More informationDiagnostic Usefulness of the Serum-Specific IgE, the Skin Prick Test and the Atopy Patch Test Compared with That of the Oral Food Challenge Test
Ann Dermatol Vol. 22, No. 4, 2010 DOI: 10.5021/ad.2010.22.4.404 ORIGINAL ARTICLE Diagnostic Usefulness of the Serum-Specific IgE, the Skin Prick Test and the Atopy Patch Test Compared with That of the
More informationA*STAR skin examination protocol
A*STAR skin examination protocol Professor Carsten Flohr Chair in Dermatology and Population Science & Consultant Dermatologist Unit for Population-Based Dermatology Research St John s Institute of Dermatology
More informationOUR BODIES. Our Bodies. This section includes: Some activities need additional guidance, or can be expanded:
OUR BODIES This section includes: Teachers Notes Male and female Differences between males and females Male and female clothes Wearing clothes Male and female underwear Label the body parts - Male Label
More informationD E R M A T O L O G Y
We customize individual prescriptions for the specific needs of our patients. F E B R U A R Y 2 0 1 3 I N S I D E T H I S I S S U E : Psoriasis Vulgaris 2 Atopic Dermatitis 3 P R E S C R I P T I O N C
More informationCall for Applications
2013 Knowledge Synthesis Grant Program Call for Applications Program Guidelines Overview Technology Evaluation in the Elderly Network (TVN or the Network) is a new network funded by the Government of Canada
More informationCHAPTER 1. Eczema Basics
CHAPTER 1 Eczema Basics Definition Eczema is an inflammatory skin condition, characterised by ichtyosis (dry skin), erythema (redness), excoriation (interruption of the skin), scratching lesions, lichenification
More informationContact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age
Contact Allergy Testing (Patch Testing) Information for parents and carers of children up to 12 years of age Dermatology Department The aim of this leaflet is to give you information about contact allergy
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Technology Appraisals and Guidance Information Services Static List Review (SLR) Title and TA publication number of static topic: Final decision: TA82;
More informationLead team presentation
Lead team presentation Dupilumab for treating adults with moderate to severe atopic dermatitis [ID1048] 1 st Appraisal Committee meeting Committee B Chair: Amanda Adler Lead team: Diar Fattah, Danielle
More informationAntidepressants for treatment of depression.
JR3 340 1 of 9 PSYCHOTROPIC MEDICATIONS PURPOSE The use of psychotropic medication as part of a youth's comprehensive mental health treatment plan may be beneficial. The administration of psychotropic
More informationEfficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema
Original Paper DOI: 10.1159/000341809 Received: February 28, 2012 Accepted after revision: June 30, 2012 Published online: August 31, 2012 Efficacy and Patient-Reported Outcomes of a New Mometasone Cream
More informationUNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Ordinary Level
www.xtremepapers.com UNIVERSITY OF CAMBRIDGE INTERNATIONAL EXAMINATIONS General Certificate of Education Ordinary Level *1991539925* BIOLOGY 5090/62 Paper 6 Alternative to Practical October/November 2012
More informationEVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS
EVALUATION OF THERAPEUTIC PROGRAMS EDUCATING AD PATIENTS AND THEIR PARENTS Rencontres 2èmes Internationales sur l Él Éducation Thérapeutique dans la Dermatite Atopique Rome, le 1er juillet 2011 Danielle
More informationDr Emmy Babor GPSI Dermatology
Dr Emmy Babor GPSI Dermatology Wrinkles Sagging Thin skin (not all areas think about soles of feet) Loss of elasticity Pigmentary changes Dryness Loss of luminosity Baldness/ grey hair Increased nose
More informationSteroid use in managing your child s Atopic Eczema
Steroid use in managing your child s Atopic Eczema Clinical Nurse Specialist for Paediatric Dermatology (01284) 713575 Step up step down approach: Addressograph Severe Call your General Practitioner (GP)
More informationEczema & Dermatitis Clinical features: Histopathological features: Classification:
Eczema & Dermatitis Eczema is an inflammatory reactive pattern of skin to many and different stimuli characterized by itching, redness, scaling and clustered papulovesicles. Eczema and dermatitis are synonymous
More informationMC IRB Protocol No.:
APPLICATION FORM - INITIAL REVIEW INSTITUTIONAL REVIEW BOARD Room 117 Main Building 555 Broadway Dobbs Ferry NY 10522 Phone: 914-674-7814 / Fax: 914-674-7840 / mcirb@mercy.edu MC IRB Protocol No.: Date
More informationClinical Trial Report Synopsis
This document has been do\vnloaded from \v ww.leo-pharma.com subject to the terms of use state on the website. It contains data and results regarding approved and non-approved uses, formulations or treatment
More informationPhysical Comorbidities of Dementia
Physical Comorbidities of Dementia Physical Comorbidities of Dementia Susan Kurrle Curran Chair in Health Care of Older People, The Faculty of Medicine, University of Sydney, Sydney, and Geriatrician
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationHearing Conservation Program
1. Introduction The University of Denver (HCP) is written in accordance with the Occupational Safety and Health Administration (OSHA) General Industry Standard Occupational Exposure to Noise CFR 1910.95
More informationCiclosporin Microemulsion for Severe Atopic Dermatitis: Experience on Adolescents and Adults in Hong Kong
ORIGINAL ARTICLES Ciclosporin Microemulsion for Severe Atopic Dermatitis: Experience on Adolescents and Adults in Hong Kong Drs. H. F. Ho, L.Y. Chong, K. M. Ho and W. K. Fung Social Hygiene Service (Dermatology),
More informationStandard operating procedure
Standard operating procedure Title: Preparation of an initial European Public Assessment Report (EPAR) for a human medicinal product following positive or negative opinion Status: PUBLIC Document no.:
More informationINFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE
INFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE Please review the following instructions as it contains important information regarding the management of your pain. Once reviewed, our
More informationSALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS
SALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS If you have a full committee review: 1. Your proposal must be submitted at minimum 14 days before the
More informationREPORT OF USE TEST UNDER DERMATOLOGIST AND OPHTHALMOLOGIST CONTROL
Client: PHENICOPTERE SP. Z O.O. ul. Nowogrodzka 18a/21 00-511 Warszawa Sample (according to declaration of the Client) EYE MAKE-UP REMOVAL GLOVE Sample received on: 06.03.2015 Analysis completed on: 08.04.2015
More informationTitle Protocol for Insect Bites Stings for Patients in MIUs and WICs
Document Control Title Protocol for Insect Bites Stings for Patients in MIUs and WICs Author Author s job title Professional Lead, Minor Injuries Unit Directorate, Logistics and Resilience Department Emergency
More informationTitle Deactivation of Implantable Cardioverter Defibrillators (ICD) towards the end of life Guidelines
Document Control Title Deactivation of Implantable Cardioverter Defibrillators (ICD) towards the end of life Guidelines Author Lead Nurse for Cardiac Support Services Northern Arrhythmia Care Coordinator
More informationDirection for Future Actions From dermatologists standpoint
Research and Reviews Direction for Future Actions From dermatologists standpoint JMAJ 52(3): 168 172, 29 Akira HATTORI,* 1 Masutaka FURUE,* 2 Michihiro HIDE,* 3 Masahiko IWAI,* 4 Shusho OKADA* 5 Abstract
More informationClinical Trial Report Synopsis
Clinical Trial Report Synopsis A phase 2a, proof of concept trial, testing twice daily application of LEO 124249 ointment 30 mg/g in the treatment of mild to moderate inverse psoriasis Design of trial:
More informationSerum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis
Clinical dermatology Original article Clinical and Experimental Dermatology Serum tryptase and (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis
More informationAfamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria This technology summary is based on information available at the time of research and a limited literature search.
More informationMEDICAL DIRECTIVE Title: Administration of Nicotine Replacement Therapy by Health Professionals at Pinewood Centre of Lakeridge Health
Approved by/date: Medical Advisory Comm. Mar 25, 2014 Authorizing physician(s)/nurse practitioner Dr Eli Sagi, Chief of Psychiatry, Medical Director, Mental Health and Pinewood Centre Dr. Ihab Sorial,
More informationTITLE: Obtaining Informed Consent of Non-English Speakers SOP #: CON-101 (formerly SM-507) Page: 1 of 7 Effective Date: 1/14/2016
SOP #: CON-101 (formerly SM-507) Page: 1 of 7 Effective Date: 1. POLICY STATEMENT: All informed consent information (initial or updates for new information) must be presented in a language that is understandable
More informationThe Burden of Atopic Dermatitis: from Population to Bedside
The Burden of Atopic Dermatitis: from Population to Bedside S028 AAD Annual Meeting March 2, 2019 Research and institutional funding Sanofi Regeneron Disclosures Consultant Honoraria Sanofi Astellas Canada
More informationTeaching Puberty: You Can Do It! Human Development & Sexual Health Curriculum Support for Grades 5 and 6
Teaching Puberty: You Can Do It! Human Development & Sexual Health Curriculum Support for Grades 5 and 6 Lesson 5: Body Awareness for Boys (to run concurrently with Body Awareness for Girls) If gender-
More informationPOSTURAL STABILITY STRENGTH & BALANCE
POSTURAL STABILITY STRENGTH & BALANCE Home Exercise Programme Text by Sheena Gawler Research Associate, Research Department of Primary Care and Population Health University College London Medical School
More informationDupixent (dupilumab)
Dupixent (dupilumab) Line(s) of Business: HMO; PPO; QUEST Integration Effective Date: TBD POLICY A. INDICATIONS The indications below including FDA-approved indications and compendial uses are considered
More informationStatistical Analysis Plans
Statistical Analysis Plans PROFESSOR CARROL GAMBLE UNIVERSITY OF LIVERPOOL Clinical Trials Lots of different types of clinical trials Various interventions Pharmaceutical/drugs regulated Regulated environment
More informationDermatology Literary Review
Emollients and ageing skin: optimising effectiveness and safety of Nursing, Vol. 25, No.11, pages 596-598. 6 Article outlines the causes of dryness in ageing skin and concludes that emollients are the
More informationEVIDENCE-BASED DERMATOLOGY: STUDY. Measuring Atopic Eczema Severity Visually
EVIDENCE-BASED DERMATOLOGY: STUDY SECTION EDITOR: MICHAEL BIGBY, MD; ASSISTANT SECTION EDITORS: DAMIANO ABENI, MD, MPH; ROSAMARIA CORONA, DSc, MD; URBÀ GONZÁLEZ, MD, PHD; ARBAR A. QURESHI, MD, MPH; MOYSES
More informationINTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION CONTENTS
INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION (Effective for assurance reports dated on or after January 1,
More informationJob Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN FORTH VALLEY Protocol Number 445 Version 1 Date protocol prepared: June 2014 Date protocol due
More informationWeb appendix: Supplementary data
Web appendix: Supplementary data Azad MA, Coneys JG, Kozyrskyj AL, Field CJ, Ramsey CD, Becker AB, Friesen C, Abou-Setta AM, Zarychanski R. Probiotic supplementation during pregnancy or infancy for the
More informationPhysiotherapy information for Achilles Tendinopathy
Physiotherapy information for Achilles Tendinopathy What is Achilles Tendinopathy? Achilles Tendinopathy is a condition that can cause pain, swelling and weakness of the Achilles Tendon. This joins your
More informationRESEARCH INVOLVING HUMAN PARTICIPANTS EXPEDITED/FULL APPLICATION
This information listed below should be submitted to Florida Tech s IRB if the proposed research has more than minimal risk (none of the exempt conditions apply) or if the research utilizes a special population
More informationPediatric Postmarketing Pharmacovigilance and Drug Utilization Review. Division of Pharmacovigilance I (DPV I) Division of Epidemiology II (DEPI II)
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance
More informationCONCORDANCE BETWEEN PRIMARY AND SECONDARY OUTCOMES IN COCHRANE REVIEWS AND CLINICAL TRIALS - JOCHEN SCHMITT -
CONCORDANCE BETWEEN PRIMARY AND SECONDARY OUTCOMES IN COCHRANE REVIEWS AND CLINICAL TRIALS - JOCHEN SCHMITT - Annual Cochrane Skin Group & CSG-COUSIN Meeting 2018 Amsterdam, 15th January Meta-epidemiological
More informationLRI Emergency Department. Burn injuries management in adults
LRI Emergency Department Clinical guideline for: Burn injuries management in adults Authors: Approved by: Martin Wiese Reena Agarwal Claire Porter EF guidelines committee Approval date: 21 Sep 16 Approval
More information(City, State, Zip Code)
This Partner Agency Agreement, dated this day of, 2015, is between COMMUNITY FOOD SHARE, INC. (CFS), whose address is 650 South Taylor Avenue, Louisville, CO 80027, and (Partner Agency) whose address is
More informationSOP-QA-30 V Scope
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Joanne Rodger, Senior R&D Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys,
More informationThe University of British Columbia Board of Governors
The University of British Columbia Board of Governors Policy No.: 13 Approval Date: May 1998 Last Revision: June 2014 Responsible Executive: Vice-President Finance Title: Serving and Consumption of Alcohol
More informationCambridge International Examinations Cambridge International General Certificate of Secondary Education
Cambridge International Examinations Cambridge International General Certificate of Secondary Education *5930765143* BIOLOGY 0610/62 Paper 6 Alternative to Practical May/June 2014 1 hour Candidates answer
More informationTITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines
TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines DATE: 08 May 2014 CONTEXT AND POLICY ISSUES Electroconvulsive therapy (ECT) is a treatment that
More informationWYNNIS L. TOM, MD: And I m Dr. Wynnis Tom. I m Associate Professor of Dermatology and Pediatrics at the University of California, San Diego.
LEARNING OBJECTIVES At the conclusion of this activity, participants should be better able to: Assess the severity of atopic dermatitis (AD) and its impact on the patient Evaluate treatment efficacy Design
More informationEverant.in/index.php/jmpr. Journal of Medical Practice and Review
Everant.in/index.php/jmpr Journal of Medical Practice and Review Real world Efficacy and Tolerance of Bepotastine, a new 2 nd generation antihistamine, in Pruritis and other symptoms associated with cutaneous
More informationCenter for Family Health Policy
Subject: Vaccine Management and Administration (Immunization) BOARD APPROVED: 7/30/96 REVISION APPROVED: 05/03/05, 04/08/08, 04/07/09, 04/12/11 Purpose: To ensure safe and appropriate storage, handling
More information